Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BY 4.0eBioMedicine

A randomised, double-blind, multicentre, placebo-controlled phase 3 efficacy, safety, and immunogenicity study of an Ad26.RSV.preF/RSV prefusion F-protein vaccine for the prevention of respiratory syncytial virus-mediated lower respiratory tract disease in adults aged 60 years and older

  • Christy A. Comeaux
  • Marco Testa
  • Efi Gymnopoulou
  • Arangassery Rosemary Bastian
  • Mauricio L. Nogueira
  • Hongxing Pan
  • Fengcai Zhu
  • Viktoriia Fursenko
  • William B. Smith
  • Patricia Junquera
  • Joris Menten
  • Matteo Loi
6 more authors
  • Edem Bassey Effiom
  • Archana M. Jastorff
  • Karin Weber
  • Ann R. Falsey
  • Benoit Callendret
  • Esther Heijnen
Open at sourceDOICite

Related

  1. Immunogenicity and safety of Sabin inactivated poliovirus vaccine in a sequential schedule with bivalent oral poliovirus vaccine in Nepal: a single-centre, double-blind, randomised, controlled, non-inferiority trial
    Arun K Sharma, Visalakshi Jeyaseelan, Sudha Basnet +8
    The Lancet Global HealthPeer-reviewedCC BY 4.0Epidemiology & public healthCrossref
  2. Immobilisation versus early active motion following primary flexor pollicis longus tendon zones 1-2 repair: protocol for a registry-based multicentre randomised controlled trial in Sweden.
    Maria Wilcke, Annika Elmstedt, Erika Nyman +5
    BMJ openPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCCrossref
  3. Effectiveness and safety of electroacupuncture as an adjunct to guideline-based usual care for acute lumbar disc herniation: a multicentre, randomised, sham-controlled trial protocol.
    Zheng Yan, Peijie You, Qilong Lai +9
    BMJ openPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCCrossref
  4. Primary repair during the neonatal period for tetralogy of Fallot (RIFAN): a multicentre randomised controlled trial protocol in China
    Han Zhongyi, Qu Yalun, Lizhi Lv +12
    BMJ OpenPeer-reviewedLicence not statedGeneral medicineCrossref
  5. Photobiomodulation therapy combined with a static magnetic field in critically ill patients receiving invasive mechanical ventilation: protocol for a multicentre randomised triple-blind placebo-controlled trial.
    Ernesto Cesar Pinto Leal-Junior, Amanda Lima Pereira, Heliodora Leão Casalechi +5
    BMJ openPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMCCrossref

Cite

BibTeXRIS
BibTeX
@article{comeaux2026randomised,
  title = {{A randomised, double-blind, multicentre, placebo-controlled phase 3 efficacy, safety, and immunogenicity study of an Ad26.RSV.preF/RSV prefusion F-protein vaccine for the prevention of respiratory syncytial virus-mediated lower respiratory tract disease in adults aged 60 years and older}},
  author = {Christy A. Comeaux and Marco Testa and Efi Gymnopoulou and Arangassery Rosemary Bastian and Mauricio L. Nogueira and Hongxing Pan and Fengcai Zhu and Viktoriia Fursenko and William B. Smith and Patricia Junquera and Joris Menten and Matteo Loi and Edem Bassey Effiom and Archana M. Jastorff and Karin Weber and Ann R. Falsey and Benoit Callendret and Esther Heijnen},
  journal = {eBioMedicine},
  year = {2026},
  month = nov,
  doi = {10.1016/j.ebiom.2026.106513},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S235239642600397X},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - A randomised, double-blind, multicentre, placebo-controlled phase 3 efficacy, safety, and immunogenicity study of an Ad26.RSV.preF/RSV prefusion F-protein vaccine for the prevention of respiratory syncytial virus-mediated lower respiratory tract disease in adults aged 60 years and older
AU  - Christy A. Comeaux
AU  - Marco Testa
AU  - Efi Gymnopoulou
AU  - Arangassery Rosemary Bastian
AU  - Mauricio L. Nogueira
AU  - Hongxing Pan
AU  - Fengcai Zhu
AU  - Viktoriia Fursenko
AU  - William B. Smith
AU  - Patricia Junquera
AU  - Joris Menten
AU  - Matteo Loi
AU  - Edem Bassey Effiom
AU  - Archana M. Jastorff
AU  - Karin Weber
AU  - Ann R. Falsey
AU  - Benoit Callendret
AU  - Esther Heijnen
PY  - 2026
DA  - 2026/11/01
JO  - eBioMedicine
DO  - 10.1016/j.ebiom.2026.106513
UR  - https://linkinghub.elsevier.com/retrieve/pii/S235239642600397X
SN  - 2352-3964
ER  -